Search research articles
Contact Us
Filters
Showing results (601-610 of 968) with videos related to
Page
of 97
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 30, 1999
Humanization of Immu31, an alpha-fetoprotein-specific antibody
Z Qu, M J Losman, K C Eliassen, et al.
Molecular Cancer Therapeutics
|
February 22, 2013
Milatuzumab-SN-38 conjugates for the treatment of CD74+ cancers
Serengulam V Govindan, Thomas M Cardillo, Robert M Sharkey, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1995
Engineering a unique glycosylation site for site-specific conjugation of haptens to antibody fragments
S Leung, M J Losman, S V Govindan, et al.
Biochemical Pharmacology
|
August 1, 1983
Pharmacological effects of non-steroidal antiinflammatory agents on prostaglandin and leukotriene synthesis in mouse peritoneal macrophages
J L Humes, S Sadowski, M Galavage, et al.
Nuclear Medicine Communications
|
May 11, 1999
Intracellular processing of 99Tcm-antibody conjugates
H Karacay, G L Ong, H J Hansen, et al.
Human Reproduction (Oxford, England)
|
September 28, 2001
The accuracy of serum interleukin-6 and tumour necrosis factor as markers for ovarian torsion
S B Cohen, A Wattiez, D Stockheim, et al.
Cancer
|
February 1, 1994
Processing of antibody-radioisotope conjugates after binding to the surface of tumor cells
M J Mattes, G L Griffiths, H Diril, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2007
Bispecific antibody pretargeting of radionuclides for immuno single-photon emission computed tomography and immuno positron emission tomography molecular imaging: an update
Robert M Sharkey, Habibe Karacay, William J McBride, et al.
Cancer Research
|
February 15, 1992
The fate of antibodies bound to the surface of tumor cells in vitro
R J Kyriakos, L B Shih, G L Ong, et al.
Blood
|
July 4, 2013
Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumab
Edmund A Rossi, David M Goldenberg, Rosana Michel, et al.
Page
of 97
Search research articles
Search
Showing results (601-610 of 968) with videos related to
Sort By:
Page
of 97
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 30, 1999
Humanization of Immu31, an alpha-fetoprotein-specific antibody
Z Qu, M J Losman, K C Eliassen, et al.
Molecular Cancer Therapeutics
|
February 22, 2013
Milatuzumab-SN-38 conjugates for the treatment of CD74+ cancers
Serengulam V Govindan, Thomas M Cardillo, Robert M Sharkey, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1995
Engineering a unique glycosylation site for site-specific conjugation of haptens to antibody fragments
S Leung, M J Losman, S V Govindan, et al.
Biochemical Pharmacology
|
August 1, 1983
Pharmacological effects of non-steroidal antiinflammatory agents on prostaglandin and leukotriene synthesis in mouse peritoneal macrophages
J L Humes, S Sadowski, M Galavage, et al.
Nuclear Medicine Communications
|
May 11, 1999
Intracellular processing of 99Tcm-antibody conjugates
H Karacay, G L Ong, H J Hansen, et al.
Human Reproduction (Oxford, England)
|
September 28, 2001
The accuracy of serum interleukin-6 and tumour necrosis factor as markers for ovarian torsion
S B Cohen, A Wattiez, D Stockheim, et al.
Cancer
|
February 1, 1994
Processing of antibody-radioisotope conjugates after binding to the surface of tumor cells
M J Mattes, G L Griffiths, H Diril, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2007
Bispecific antibody pretargeting of radionuclides for immuno single-photon emission computed tomography and immuno positron emission tomography molecular imaging: an update
Robert M Sharkey, Habibe Karacay, William J McBride, et al.
Cancer Research
|
February 15, 1992
The fate of antibodies bound to the surface of tumor cells in vitro
R J Kyriakos, L B Shih, G L Ong, et al.
Blood
|
July 4, 2013
Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumab
Edmund A Rossi, David M Goldenberg, Rosana Michel, et al.
Page
of 97